Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer

CardioVascular and Interventional Radiology

Volumn 32, Issue 4, 2009, Pages 679-686

  Seki, Hiroshi ^a   Ozaki, Toshirou ^a   Shiina, Makoto ^a  

^a NIIGATA CANCER CENTER HOSPITAL   (Japan)

Author keywords

Chemotherapy; Colorectal cancer; Hepatic artery; Liver metastases

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGED; ALOPECIA; ANEMIA; ARTERIOGRAPHY; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DIGITAL SUBTRACTION ANGIOGRAPHY; FATIGUE; FEMALE; HUMAN; HYPERSENSITIVITY; LEUKOPENIA; LIVER METASTASIS; MALE; NAUSEA; OVERALL SURVIVAL; PRIORITY JOURNAL; SENSORY NEUROPATHY; THROMBOCYTOPENIA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATHETERS, INDWELLING; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 67650711214     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-009-9547-1     Document Type: Article

References (35)

1. B van Ooijen T Wiggers S Meijer 1992 Hepatic resections for colorectal metastases in the Netherlands. A multi-institutional 10-year study Cancer 70 28 34
2. AE Chang PD Schneider PH Sugarbaker 1987 A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases Ann Surg 206 685 693 (Pubitemid 18056182)
3. N Kemeny J Daly B Reichman 1987 Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma A randomized trial. Ann Intern Med 107 459 465 (Pubitemid 17149758)
4. DC Hohn RJ Stagg MA Friedman 1989 A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial J Clin Oncol 7 1646 1654 (Pubitemid 19272834)
5. JK Martin MJ O'Connell HS Wieand 1990 Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer A randomized trial. Arch Surg 125 1022 1027 (Pubitemid 20249340)
6. P Rougier A Laplanche M Huguier 1992 Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial J Clin Oncol 10 1112 1118
7. TG Allen-Mersh S Earlam C Fordy 1994 Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases Lancet 344 1255 1260 (Pubitemid 24334681)
8. TG Allen-Mersh C Glover C Fordy 2000 Randomized trial of regional plus systemic fluorinated pyrimidine compared with systemic fluorinated pyrimidine in treatment of colorectal liver metastases Eur J Surg Oncol 26 468 473 (Pubitemid 30707505)
9. M Lorenz HH Muller 2000 Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma J Clin Oncol 18 243 254 (Pubitemid 30056411)
10. DJ Kerr CS McArdle J Ledermann 2003 Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial Lancet 361 368 373 (Pubitemid 36164968)
11. NE Kemeny D Niedzwiecki DR Hollis 2006 Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481) J Clin Oncol 24 1395 1403 (Pubitemid 46622004)
12. A Grothey D Sargent RM Goldberg 2004 Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment J Clin Oncol 22 1209 1214 (Pubitemid 41079833)
13. RM Goldberg DJ Sargent RF Morton 2004 A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 23 30 (Pubitemid 41095110)
14. CH Köhne E van Cutsem J Wils 2005 Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986 J Clin Oncol 23 4856 4865 (Pubitemid 46223990)
15. G Colucci V Gebbia G Paoletti 2005 Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale J Clin Oncol 23 4866 4875 (Pubitemid 46223991)
16. C Tournigand T André E Achille 2004 FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J Clin Oncol 22 229 237 (Pubitemid 41095086)
17. ML Rothenberg AM Oza RH Bigelow 2003 Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial J Clin Oncol 21 2059 2069 (Pubitemid 46606353)
18. H Ulrich-Pur GV Kornek W Fiebiger 2001 Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy Ann Oncol 12 1269 1272 (Pubitemid 32994756)
19. SH Park JY Sung SH Han 2005 Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX-4) combination chemotherapy as second-line treatment in advanced colorectal cancer patients with irinotecan failure: a Korean single-center experience Jpn J Clin Oncol 35 531 535 (Pubitemid 41573943)
20. A Falcone S Ricci I Brunetti 2007 Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest J Clin Oncol 25 1670 1676 (Pubitemid 46797946)
21. H Hurwitz L Fehrenbacher W Novotny 2004 Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335 2342 (Pubitemid 38702844)
22. Giantonio BJ, Catalano PJ, Meropol NJ, et al. (2007) Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 20;25:1539-1544 (Pubitemid 46733080)
23. N Kemeny D Gone LD Sullivan 2001 Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer J Clin Oncol 19 2687 2695 (Pubitemid 32441374)
24. N Kemeny W Jarnagin P Paty 2005 Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer J Clin Oncol 23 4888 4896 (Pubitemid 46223994)
25. M Ducreux M Ychou A Laplanche 2005 Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the Gastrointestinal Group of the Federation Nationale des Centres de Lutte Contre le Cancer J Clin Oncol 23 4881 4887 (Pubitemid 46223993)
26. B Neyns Y Van Nieuwenhove M Aerts 2006 Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases Anticancer Res 26 611 619 (Pubitemid 43206025)
27. A Del Freo G Fiorentini F Sanguinetti 2006 Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer In Vivo 20 743 746 (Pubitemid 46061613)
28. V Boige D Malka D Elias 2008 Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure Ann Surg Oncol 15 219 226
29. MM Oken RH Creech DC Tormey 1982 Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 649 655 (Pubitemid 13149996)
30. Y Arai Y Inaba Y Takeuchi 1997
31. T Tanaka Y Arai Y Inaba 2003 Radiologic placement of side-hole catheter with tip fixation for hepatic arterial infusion chemotherapy J Vasc Interv Radiol 14 63 68 (Pubitemid 36134075)
32. T Yamagami Y Kato S Iida 2005 Management of end hole in placement of port-catheter system for continuous hepatic arterial infusion chemotherapy using the fixed catheter tip method Am J Roentogenol 184 1332 1339 (Pubitemid 43821923)
33. H Seki T Ozaki M Shiina 2008 Side-hole catheter placement for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer: long-term treatment and survival benefit Am J Roentogenol 190 111 120
34. Y Arai Y Inaba Y Takeuchi 1997 Intermittent hepatic arterial infusion of high-dose 5FU on a weekly schedule for liver metastases from colorectal cancer Cancer Chemother Pharmacol 40 526 530 (Pubitemid 27389295)
35. P Therasse SG Arbuck EA Eisenhauer 2000 New guidelines to evaluate the response to treatment in solid tumors European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 205 216 (Pubitemid 30099779)